Affordable Access

Publisher Website

Calcium-channel blockers and the hepatorenal syndrome

Authors
Journal
Medical Hypotheses
0306-9877
Publisher
Elsevier
Publication Date
Volume
22
Issue
4
Identifiers
DOI: 10.1016/0306-9877(87)90027-2

Abstract

Abstract It is suggested that calcium-channel blockers may be the agents of choice for treating the renal dysfunction associated with the hepatorenal syndrome because these agents may be effective in reversing the episodic renal vasospasm which characterizes this disorder.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Parkinsonian syndrome and calcium channel blockers...

on Prescrire international April 2003

Calcium channel blockers.

on The Australian and New Zealand... December 1990

Calcium channel blockers.

on Pediatric nursing 1986
More articles like this..